The control and Cur-solution groups presented high heterogeneity and visible mitotic figures, indicating high malignancy, whereas the TF-Cur-Nio group presented fewer tumor cells, lower cell density, and no visible mitotic figures, suggesting a better anti-glioma effect. This evidence concerns the gene TF and glioma.